Top Biopsy Device Companies in 2025: Leaders in Medical Diagnostics
15 May, 2025

Biopsy instruments are instruments that medical specialists use to acquire tissue samples from the body to undergo examination and diagnosis, for instance, detecting diseases like cancer. They enable physicians to capture cells or tissue from organs of the body like the breast, liver, lung, skin, or lymph glands. Under examination by a microscope, these tissues determine if they exist, where they are found, and in what manner.

Common biopsy instruments are needle biopsy instruments (fine-needle aspiration and core-needle biopsy), surgical biopsy instruments, forceps, punch biopsy instruments, and vacuum-assisted devices. Some instruments are utilized with imaging guidance (ultrasound, CT, or MRI) for precision.

Globally, biopsy instruments play a critical role in cancer diagnosis, leading to early detection and treatment planning. Increased prevalence of cancer, increased awareness, and improving technology are driving worldwide demand, especially in Europe, North America, and emerging markets in Latin America and Asia-Pacific. Biopsies also find applications for diagnosing infection, inflammatory disease, and rejection after transplantation. Biopsy Devices market will be valued at US$ 4.02 billion in 2033, growing from US$ 2.43 billion in 2024 at a CAGR of 5.75% between 2025 and 2033.

A biopsy device is a medical tool used to collect tissue samples for examination, often to identify abnormalities like cancer. These devices can be used on organs such as the liver, lungs, prostate, or breast. Types of biopsy devices include vacuum-assisted, surgical, and needle-based systems. Guided by imaging techniques like MRI, CT, or ultrasound, they provide a minimally invasive method for early disease detection, treatment planning, and monitoring therapy progress.

The North American market for biopsy devices is growing with increasing demand for early cancer diagnosis, fueled by growing incidence rates of breast, lung, and prostate cancers. Advances in technology such as image-guided and minimally invasive procedures improve patient comfort and accuracy. Positive reimbursement policies, increased healthcare expenditure, and the need for personalized therapies also contribute to market growth. Also, knowledge about early disease detection and innovations using AI and digital pathology drive the market growth. The market will grow from US$ 835.19 million in 2024 to US$ 1,303.45 million in 2033 at a CAGR of 5.07% during 2025-2033.

Biopsy devices are medical equipment employed to gather small tissue samples for diagnostic testing, essential to diagnose diseases such as cancer, infections, and inflammatory diseases. Methods are fine needle aspiration, core needle biopsy, and surgical biopsy. High-quality materials are used to provide accuracy and least discomfort to patients. In Europe, the increase in cancer cases, especially among women for breast and lung cancer, is leading to demand for these devices, enabling minimally invasive procedures with reduced risks and faster recovery. Biopsy devices are used in hospitals, clinics, and research centers, leading to innovation in precision medicine. Image-guided technology such as MRI or ultrasound improves patient care and diagnostic precision. The European market for biopsy devices is anticipated to grow at a CAGR of 6.01% from 2025 to 2033 and hit US$ 1,137.2 million by 2033 from US$ 672.6 million in 2024.

Biopsy devices are essential for cancer and other conditions due to lifestyle modifications and aging in China. Technological advancements, such as ultrasound-guided and robotic-assisted systems, have improved accuracy and patient comfort. With a focus on early disease detection and enhanced healthcare infrastructure, the adoption of these devices has increased across hospitals and diagnostic centers. The Chinese biopsy devices market is expected to rise from around US$ 612.62 million in 2024 to US$ 1,131.98 million by 2033, at a CAGR of 7.06% from 2025 to 2033.

Discover key trends, growth opportunities, and major challenges shaping the Biopsy Device Industry in Renub Research’s latest in-depth market report. Download your free sample now

Top Biopsy Device Companies & Profiles

Cardinal Health, Inc.

Year of establishment: 1971

Head office: United States

Website: www.cardinalhealth.com/en.html

Cardinal Health Inc (Cardinal Health) offers integrated healthcare products and services. The primary activities of the company are the distribution of pharmaceuticals, manufacturing and distribution of medical and laboratory products, and performance and data solutions for healthcare facilities. It distributes branded and generic drugs, specialty pharmaceuticals, over-the-counter healthcare and consumer products, medical equipment, surgical devices and laboratory products. It also has nuclear pharmacies and cyclotron facilities and produces its own brand of private branded medical and surgical products. Its strengths lie in four domains: logistics, product, business and patient solutions. Its customers are retail consumers like chain and independent drug stores and pharmacies in supermarkets and mass merchandisers, hospitals, ambulatory care centers, physician offices, clinical laboratories and alternative care providers like mail order customers. It also offers cost effective solutions with an efficient supply chain. The business is headquartered in the US, Canada, Europe, Australia, China and Japan.

Hologic Inc.

Foundation: 1985

Headquarters:  United States

Website: www.hologic.com

Hologic Inc (Hologic) creates, produces, and provides medical imaging systems, diagnostic products, and surgical products. It provides products facilitating the diagnosis of human disease; breast imaging and related products and accessories; GYN surgical products, such as endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products like dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company provides its solutions to surgeons, hospitals, clinical laboratories, and healthcare providers. Hologic sells its products and services through direct sales and an independent network of distributors and sales representatives. The company has operations in Europe, the Americas and Asia-Pacific.

Danaher Corporation

Establishment: 1984

Headquarters:  United States

Website: www.danaher.com

Danaher Corp (Danaher) is a science and technology firm that does business in biotechnology, life sciences, and diagnostics. The firm supplies a broad assortment of testing instruments, medical diagnostic solutions, life science research equipment, professional microscopes, reagents and mass spectrometry, genomic consumables, filtration and flow cytometry, genomics, laboratory automation, centrifugation, particle counting, and characterization businesses. Danaher sells its products and services to pharmaceutical and biotechnology businesses, healthcare professionals, and research organizations through independent distributors in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. It has plants in Europe, Australia, Asia, and the Americas.

Becton, Dickinson and Company

Founding: 1897

Headquarter:  United States

Website: https://www.bd.com

Becton Dickinson and Co (BD) is a medical technology company. It produces and distributes medical devices, medical supplies, laboratory equipment, and diagnostic products. The products offered by the company include vascular and urology devices, surgical products, molecular diagnostic systems, infusion pumps, pre-fillable drug delivery systems, hemodynamic monitoring systems, and cell analysis solutions. BD's products are targeted at healthcare facilities, physicians, life science scientists, clinical research laboratories, the pharmaceutical industry, and the consumer. BD is represented in various countries with its manufacturing facilities across Bosnia and Herzegovina, Brazil, Canada, the US, the Dominican Republic, France, Germany, Hungary, India, Japan, Mexico, among others.

Boston Scientific Corporation

Establishment: 1979

Headquarters:  United States

Website: www.bostonscientific.com/en-US/Home.html

Boston Scientific Corp (Boston Scientific) is a medical technology firm that designs, develops, and commercializes products for a variety of interventional medical specialties. Products are provided by the company in such fields as electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology, and vascular surgery. Boston Scientific provides products to hospitals, clinics, outpatient facilities, and medical offices worldwide. The company has manufacturing operations in the US, Ireland, Costa Rica, Brazil, Malaysia and Puerto Rico. It markets products directly and indirectly through a network of distributors and dealers in Europe, the Middle East, Africa, Asia Pacific and the Americas.

Medtronic plc.

Formation: 1949

Head Office:  Ireland

Website: www.medtronic.com

Medtronic plc (Medtronic) is a medical technology company which designs, develops, manufactures and markets medical devices and solutions. The company's principal business is research, design, manufacturing, and sales of products of biomedical engineering. It deals in products for the treatment of heart valve diseases, heart failure, coronary artery disease, aortic, peripheral vascular, venous renal and neurological disorders and diseases, spine and musculoskeletal diseases and ear, nose, and throat diseases. Medtronic also deals in biologic solutions for the orthopedic and dental industries. The company distributes products to hospitals, third-party healthcare providers, clinics, institutions such as governmental healthcare programs, distributors, and group purchasing organizations in Asia Pacific, Europe, the Americas, the Middle East and Africa.

Olympus Corporation

Established: 1919

Head Office:  Japan

Website: www.olympus.co.jp

Olympus Corp (Olympus) is a medical technology firm. It designs, produces, and markets equipment and devices for medical, healthcare, imaging, information, and other industrial segments. The main products of Olympus are endoscopes, laparoscopes, video imaging systems, surgical energy devices, and disease prevention, detection, and treatment instruments. The products of the company have application in numerous medical areas such as endotherapy, respiratory, urology, gynecology, ear, nose, and throat, and surgical devices. Biomedical materials and system development are also provided by the company. It has operational locations in the Americas, Europe, and Asia-Pacific.

CONMED Corporation

Foundation: 1970

Headquarters: United States

Website: www.conmed.com

ConMed Corp (ConMed) is a medical technology company that designs and markets surgical instruments and devices for minimally invasive procedure and monitoring. The company's significant products are arthroscopes, reconstructive systems, bronchoscopy instruments, endoscopic ligator kits, balloons for stone removal, trocars, graspers, scissors, suction irrigation instruments, thermal tissue fusion systems, electrosurgical generators, smoke evacuation pencils, pencil sheaths, saws, blades, endo mechanical instrumentation, and surgical visualization products. ConMed serves orthopedic, general surgery, gynecology, gastroenterology, pulmonology, anesthesiology, and sports medicine markets. It distributes its products directly by a sales force and medical specialty distributors. ConMed is present in the Americas, Europe, the Middle East, and Asia-Pacific.